Viz.ai Launches AI-Powered Pulmonary Care Suite for Hospitals

The newly introduced Viz Pulmonary Suite combines acute and chronic pulmonary care workflows into a single platform integrated with electronic health record (EHR) systems.

Viz.ai has launched an AI-powered pulmonary care platform aimed at improving disease detection, care coordination, and workflow management for healthcare organizations.

The newly introduced Viz Pulmonary Suite combines acute and chronic pulmonary care workflows into a single platform integrated with electronic health record (EHR) systems. The company said the platform is designed to help reduce missed diagnoses and treatment delays for major pulmonary conditions.

The suite supports care management for conditions including chronic obstructive pulmonary disease (COPD), pulmonary embolism, and lung nodules.

According to Viz.ai, the platform includes AI tools capable of identifying pulmonary embolism directly from medical imaging scans and detecting clots that may require treatment. The company said the technology is intended to accelerate clinical decision-making and improve patient outcomes.

Viz.ai Chief Medical Officer Tim Showalter, MD, said the platform also includes chart summarization capabilities through EHR integration, allowing clinicians to quickly review patient information and recommended next steps based on clinical guidelines.

The company stated that integrating pulmonary workflows into a single platform enables clinicians to identify patients faster and coordinate treatment more efficiently across care teams.

In March, Viz.ai also launched Viz Agent Studio, an agentic AI platform that allows health systems to create and deploy customizable care pathways using natural language inputs.

According to the company, the tool enables healthcare organizations to convert clinical guidelines into scalable workflows across enterprise systems.

Founded in 2016, Viz.ai develops AI-based disease detection and care coordination technologies for hospitals and healthcare systems. The company said its platform is currently deployed across approximately 2,000 hospitals in the United States.

CEO and co-founder Chris Mansi, MD, previously stated that the company’s hospital network reaches nearly two-thirds of the U.S. population.

The launch comes amid growing adoption of AI-based workflow automation and clinical decision support tools across healthcare systems, particularly in areas requiring rapid diagnosis and coordinated specialty care.

Stay tuned for more such updates on Digital Health News